510(k) device
AXS Vecta Aspiration System
Stryker Neurovascular · Catheter, Thrombus Retriever (NRY, Class II) · First FDA decision Apr 24, 2019, newest Jul 30, 2019Acute ischemic stroke
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
3
Naming "AXS Vecta Aspiration"
MAUDE reports
0
Brand "AXS Vecta Aspiration", since 2015
PubMed studies
2
Mentioning "AXS Vecta Aspiration"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AXS Vecta Aspiration System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K191768 · Decided Jul 30, 2019 · 29 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
K190212 · Decided Apr 24, 2019 · 79 days after receipt
Device type: Catheter, Thrombus Retriever (NRY) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "AXS Vecta Aspiration", any status and sponsor, newest update first.
- Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKePivotal-lookingRecruiting
Raul NogueiraAcademic, hospital or other
NCT05983757 · 584 participants (planned) · Start Apr 2, 2024 · Primary completion Jul 2027
Device: Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion · For: Ischemic Stroke
Sites: Atlanta, Georgia; Iowa City, Iowa; Toledo, Ohio · 4 sites in all
Stryker NeurovascularPublic (SYK)
NCT03845491 · 1,492 participants · Start Jan 24, 2019 · Primary completion Apr 11, 2022
Device: Mechanical Thrombectomy · For: Ischemic Stroke
Sites: Mesa, Arizona; Fontana, California; Los Angeles, California · 72 sites in all
- Endovascular Therapy for Large Core Patients With Uncertain Response to ThrombectomyEnrolling by invitation
Stanford UniversityAcademic, hospital or other
NCT06961487 · 50 participants (planned) · Start Jul 26, 2024 · Primary completion May 2028
Device: Endovascular thrombectomy with any FDA-approved device · For: Stroke, Acute; Ischemic Stroke, Acute
Sites: Palo Alto, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AXS Vecta Aspiration", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NRY
6,841 reports: 3,541 malfunction, 2,671 injury, 627 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "AXS Vecta Aspiration"[tiab]. The summary above synthesizes these.
- Initial Experience in Direct Aspiration Thrombectomy Using a Novel 0.071-Inch Aspiration Catheter.
Almallouhi E, Anadani M, Al Kasab S, et al. · World Neurosurg · 2019
- A prospective, randomized, controlled, interventional clinical trial to evaluate the safety and efficacy of the medical monopoint reperfusion system for aspiration thrombectomy in acute ischemic stroke patients (SUMMIT MAX): Trial rationale and design.
Dabus G, Puri AS, McGuinness B, et al. · Interv Neuroradiol · 2026Clinical Trial Protocol
Other devices of this type
Also filed under product code NRY.
- Penumbra System (Thunderbolt Aspiration Tubing)Penumbra, Inc. · 510(k) 2026
- Riptide Aspiration SystemMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2024
- Route 92 Medical Full Length 046 Reperfusion System and Aspiration Tubing SetRoute 92 Medical, Inc. · 510(k) 2026
- EMBOTRAP III Revascularization DeviceNeuravi Limited · 510(k) 2025
- Solitaire Platinum Revascularization Device, 6x40 mmMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2017
- Merci Retriever, Models 90050, 90060, 90066, 90070, 90110, 90111, 90112, 90113Concentric Medical, Inc. · 510(k) 2009
- Modified Merci Retriever, Model 90060Concentric Medical, Inc. · 510(k) 2007
- Millipede SystemPerfuze, Ltd. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.